Tenaya therapeutics appoints amy burroughs to board of directors

South san francisco, calif., dec. 07, 2022 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the appointment of amy burroughs to its board of directors. ms. burroughs currently serves as president and chief executive officer of cleave therapeutics, a clinical-stage company focused on developing novel medicines for oncology and neurodegenerative diseases.
TNYA Ratings Summary
TNYA Quant Ranking